Add-on Acquisition • Medical Products

Terumo Acquires OrganOx

On August 24, 2025, Terumo acquired medical products company OrganOx from Amadeus Capital Partners for 1.5B USD

Acquisition Context
  • This is Terumo’s 8th transaction in the Medical Products sector.
  • This is Terumo’s 2nd largest (disclosed) transaction.
  • This is Terumo’s 1st transaction in the United Kingdom.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free


M&A Deal Summary

Date August 24, 2025
Target OrganOx
Sector Medical Products
Buyer(s) Terumo
Sellers(s) Amadeus Capital Partners
Deal Type Add-on Acquisition
Deal Value 1.5B USD
Advisor(s) Perella Weinberg Partners
Piper Sandler & Co. (Financial)
Latham & Watkins (Legal)

Target Company

OrganOx

Oxford, United Kingdom
OrganOx is a medical technology company, that has developed metra, a revolutionary device for storing livers at normal body temperatures for extended periods of time, which is commercially available within the EU. OrganOx was founded in 2008 and is based in Oxford, United Kingdom.
Explore More Deals

Browse All 215,130 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Terumo

Tokyo, Japan

Category Company
Founded 1921
Sector Medical Products
Employees28,294
Revenue 1.04T JPY (2025)
DESCRIPTION

Terumo is a medical products company. Terumo was founded in 1921 and is based in Tokyo, Japan.


Deal Context for Buyer #
Overall 10 of 10
Sector: Medical Products 8 of 8
Type: Add-on Acquisition 7 of 7
Country: United Kingdom 1 of 1
Year: 2025 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-24 HOS

Phoenix, Arizona, United States

HOS specializes in predictive analytics and clinical decision support that enable healthcare organizations to deliver personalized, predictive insights at the point of care, resulting in significant and measurable improvements in clinical, patient, and financial outcomes. HOS is based in Phoenix, Arizona.

Buy -

Seller Profile 1

SELLER

Amadeus Capital Partners

Investor Investor Investor Investor Investor


Category Venture Capital Firm
Founded 1997
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Amadeus Capital Partners is an early late-stage investor in high growth European technology companies. Specific areas of interest include AI & machine learning, online consumer services, cybersecurity, digital health and medical technology, digital media, enterprise SaaS, fintech, and insurtech. Amadeus Capital Partners was formed in 1997 and is based in London, United Kingdom.


Deal Context for Seller #
Overall 24 of 26
Sector: Medical Products 2 of 2
Type: Add-on Acquisition 18 of 20
Country: United Kingdom 13 of 15
Year: 2025 1 of 3
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-08-08 Lumeon

Boston, Massachusetts, United States

Lumeon enables healthcare organizations to orchestrate and automate systems and processes, bringing situational awareness to care operations to deliver high-performance, team-centered healthcare. Lumeon Care Pathway Management (CPM) platform and suite of solutions empower health organizations to take control of their end-to-end care delivery model and maximize the use of resources. Lumeon was founded in 2005 and is based in Boston, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-09-02 Congenica

Cambridge, United Kingdom

Congenica is a digital health company offering a clinical decision support platform for accelerated genomic data interpretation. Congenica software enables genomic medicine by integrating genetic data into healthcare, empowering clinicians to provide life-changing answers that transform the lives of individuals, patients, and their families. Congenica was founded in 2012 and is based in Cambridge, England.

Sell -